Autobahn Labs

Autobahn Labs is a new model for accelerating early drug discovery and development. By collaborating with academic institutions and scientists, we help identify the most promising early-stage research projects that can lead to the development of meaningful new therapies for patients.Autobahn Labs was founded by Samsara BioCapital, a leader in life sciences investment, Evotec, a global leader in drug discovery and development research, and KCK Ltd., a family investment fund focused on projects that are scientifically and technologically challenging. By combining Samsara’s long-term investment philosophy with Evotec’s world-class drug discovery and development capabilities, Autobahn Labs believes it can improve patient health by advancing early-stage academic research projects that have been identified as capable of inspiring the development of new therapies.